FDA Probes Yaz, Others Over Blood Clot Risks
The U.S. Food and Drug Administration said Tuesday that it launched an investigation into whether birth control pills that contain drospirenone, like Bayer AG's Yasmin and Yaz, put users at increased...To view the full article, register now.
Already a subscriber? Click here to view full article